Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection-Reference-Cited by-同舟云学术

Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection

Published:2012-07 Issue:3 Volume:131 Page:317-324
ISSN:0014-4894
Container-title:Experimental Parasitology
language:en
Short-container-title:Experimental Parasitology

Author:

Daifalla Nada S.,Bayih Abebe Genetu,Gedamu Lashitew

Publisher

Elsevier BV

Subject

Immunology,General Medicine,Parasitology,Infectious Diseases

Reference48 articles.

1. The leishmaniases as emerging and reemerging zoonoses;Ashford;Int. J. Parasitol.,2000

2. Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice;Badiee;Clin. Vaccine Immunol.,2008

3. Intradermal immunization improves protective efficacy of a novel TB vaccine candidate;Baldwin;Vaccine,2009

4. Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion;Baldwin;Vaccine,2009

5. Complexities of assessing the disease burden attributable to leishmaniasis;Bern;PLoS Neglected Trop. Diseases,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leishmania vaccine development: A comprehensive review;Cellular Immunology;2024-05

2. Toll-like Receptor-9 (TLR-9) Signaling Is Crucial for Inducing Protective Immunity following Immunization with Genetically Modified Live Attenuated Leishmania Parasites;Pathogens;2023-03-29

3. Development of nano-carriers for Leishmania vaccine delivery;Expert Opinion on Drug Delivery;2020-01-14

4. Superoxide Dismutase B1, an Exacerbatory Antigen Elicits Interleukin-10 Production in Murine Leishmania major Infection;Archives of Clinical Infectious Diseases;2019-02-27

5. Immune Response and Protective Efficacy of a Heterologous DNA-Protein Immunization withLeishmaniaSuperoxide Dismutase B1;BioMed Research International;2017